CLINT SALO: Open Payments
NPI 1811159221 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,072 in 31 payments from 6 companies in 2025. Trend: 2023 $854 · 2024 $618 · 2025 $1,072
Food & beverage: $1,072
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $402 |
| Neurocrine BioSciences, Inc. | 12 | $398 |
| ACADIA Pharmaceuticals Inc | 3 | $139 |
| Alkermes, Inc. | 3 | $86 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: COBENFY, INGREZZA, NUPLAZID, ARISTADA, INVEGA SUSTENNA, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
